You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Patent: 9,662,450


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,662,450
Title:Plasma or CVD pre-treatment for lubricated pharmaceutical package, coating process and apparatus
Abstract: An article is described including an article surface, a primer coating or layer of SiOx, SiO.sub.xC.sub.y or SiN.sub.xC.sub.y applied to the article surface, and a deposit of lubricant applied to the primer coating or layer. The primer coating or layer of SiO.sub.x, SiO.sub.xC.sub.y or SiN.sub.xC.sub.y is applied by chemical vapor deposition of a polysiloxane or polysilazane precursor in the presence of oxygen. A first deposit of lubricant is applied to the primer coating or layer. The primer coating or layer improves the adhesion or wetting of the lubricant on the surface to be lubricated. Examples of such an article are a prefilled syringe having a barrel with a lubricated interior portion and a plunger tip that slides along it. Another example of such an article is a vial having a lubricated opening to receive a septum. Another aspect of the invention is a method of making such an article.
Inventor(s): Jones; Joseph A. (Birmingham, AL), Weikart; Christopher (Auburn, AL), Martin; Steven J. (Midland, MI)
Assignee: SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL)
Application Number:14/194,221
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 9,662,450

Introduction

United States Patent 9,662,450, like any other patent, is a complex document that requires a thorough analysis to understand its claims, scope, and position within the broader patent landscape. This analysis will delve into the key aspects of the patent, including its claims, the legal framework governing it, the impact of recent legislative and technological changes, and strategies for navigating the patent system.

Understanding the Patent

What Are Patents?

Patents are a form of intellectual property that grant their holders the exclusive right to make, use, sell, offer to sell, or import their inventions for a limited period of time. This exclusivity is granted in exchange for the public disclosure of the invention[2].

Patent 9,662,450 Overview

To analyze Patent 9,662,450, one must first understand its specific claims and the subject matter it covers. This involves reviewing the patent's abstract, detailed description, and claims section. The claims define the scope of the invention and are crucial for determining what is protected by the patent.

Claims Analysis

Claim Construction

The claims of a patent are interpreted using the principles of claim construction. This process involves determining the meaning of the claim terms as understood by a person of ordinary skill in the relevant art. The Supreme Court has established guidelines for claim construction, emphasizing the importance of understanding the context in which the claims are made[2].

Eligible Subject Matter

The Patent Act allows patents on new and useful "process, machine, manufacture, or composition of matter, or any improvement thereof." However, laws of nature, natural phenomena, and abstract ideas are not patentable. The Alice/Mayo test is used to determine if a patent claim is directed to ineligible subject matter and whether it contains an "inventive concept" that transforms the nature of the ineligible concept[2].

Legal Framework and Recent Changes

The Leahy-Smith America Invents Act (AIA)

The AIA, enacted in 2011, is a significant piece of legislation that has impacted the U.S. patent system. It created the Patent Trial and Appeal Board (PTAB) and introduced new administrative challenges to patent validity, such as inter partes review (IPR) and post-grant review (PGR). These proceedings allow for faster and less expensive challenges to patent validity compared to federal court litigation[2].

PTAB and Administrative Challenges

PTAB administers IPR and PGR proceedings, which are decided by a panel of three administrative patent judges. These proceedings have been instrumental in improving patent quality and providing a more efficient system for challenging patents that should not have been issued. The use of PTAB has been particularly beneficial for entities accused of patent infringement, as it offers a faster and less costly alternative to judicial proceedings[2].

Impact of AI on Patent Searches and Prosecution

AI in Prior Art Searches

The integration of AI into the patent evaluation process has transformed prior art searches. AI tools can automate laborious searches, identify relevant prior art more efficiently, and assist examiners in making more accurate patentability assessments. However, there are concerns about the volume of AI-generated disclosures and their impact on patentability[3].

AI and Inventorship

Current U.S. patent laws require human inventorship. While AI-assisted inventions are not categorically unpatentable, the issue of whether an AI system's autonomously-generated disclosures can qualify as prior art remains unresolved. The USPTO has issued guidance emphasizing the need for significant contributions from natural persons to qualify for inventorship[3][5].

Navigating the Patent System

Resources for Patent Searches

Several resources are available for conducting thorough patent searches. The USPTO Public Search Facility and Patent and Trademark Resource Centers (PTRCs) provide access to patent and trademark information. The Electronic Official Gazette and the Common Citation Document (CCD) application are also valuable tools for searching and analyzing patent data[4].

Global Dossier

The Global Dossier service allows users to access the file histories of related applications from participating IP Offices, providing a comprehensive view of the patent family and related documentation. This service is particularly useful for managing international patent portfolios[4].

Strategies for Patent Holders and Challengers

Leveraging PTAB Proceedings

For entities facing patent infringement claims, leveraging PTAB proceedings can be a strategic move. IPR and PGR offer a faster and more cost-effective way to challenge patent validity compared to federal court litigation. However, the decision to pursue these proceedings should be based on a thorough analysis of the patent's claims and the likelihood of success[2].

Utilizing AI Tools

Patent applicants and examiners can benefit from AI tools in conducting prior art searches and drafting patent documents. However, it is crucial to verify the accuracy of AI-generated content to ensure compliance with USPTO guidelines and avoid introducing inaccurate statements into the record[3][5].

Case Studies and Industry Insights

Real-World Applications

Understanding how similar patents have been challenged or upheld can provide valuable insights. For instance, cases decided by the Supreme Court involving PTAB proceedings can offer guidance on the interpretation of patent claims and the application of the Alice/Mayo test[2].

Expert Opinions

Industry experts often highlight the importance of thorough prior art searches and the strategic use of PTAB proceedings. They also emphasize the need for continuous adaptation to changes in patent law and technology, such as the integration of AI tools[3].

Statistics and Trends

Patent Litigation Costs

Litigating a patent case in federal court can be costly, with average legal costs exceeding $1 million. In contrast, PTAB proceedings are generally faster and less expensive, making them an attractive option for challenging patent validity[2].

AI Adoption in Patent Searches

The use of AI in patent searches has increased significantly since 2020. According to the USPTO, AI tools have improved the efficiency and accuracy of prior art searches, although there are ongoing debates about their impact on patent quality and the volume of AI-generated disclosures[3].

Key Takeaways

  • Patent Claims and Scope: Understanding the specific claims of a patent is crucial for determining its scope and validity.
  • Legal Framework: The AIA and PTAB proceedings have significantly impacted the U.S. patent system, offering faster and less costly ways to challenge patent validity.
  • AI Integration: AI tools are transforming prior art searches and patent prosecution, but their use must be carefully managed to ensure compliance with USPTO guidelines.
  • Strategic Use of Resources: Leveraging resources like the Global Dossier and PTAB proceedings can be strategic for both patent holders and challengers.
  • Continuous Adaptation: The patent landscape is evolving, and practitioners must adapt to changes in law and technology to remain effective.

FAQs

Q1: What is the purpose of the Patent Trial and Appeal Board (PTAB)? The PTAB is a tribunal within the USPTO that administers proceedings to challenge the validity of patents previously granted by the USPTO, aiming to improve patent quality and provide a more efficient system for challenging patents[2].

Q2: How has AI impacted patent prior art searches? AI has significantly improved the efficiency and accuracy of prior art searches, but it also raises concerns about the volume of AI-generated disclosures and their impact on patentability[3].

Q3: What is the Alice/Mayo test, and how is it used? The Alice/Mayo test is used to determine if a patent claim is directed to ineligible subject matter (laws of nature, natural phenomena, or abstract ideas) and whether it contains an "inventive concept" that transforms the nature of the ineligible concept[2].

Q4: What resources are available for conducting thorough patent searches? Resources include the USPTO Public Search Facility, Patent and Trademark Resource Centers (PTRCs), the Electronic Official Gazette, and the Common Citation Document (CCD) application[4].

Q5: Can AI systems be considered inventors under current U.S. patent law? No, current U.S. patent laws require human inventorship. While AI-assisted inventions are not categorically unpatentable, autonomously-generated disclosures by AI systems do not qualify as inventorship[3][5].

Sources

  1. NYPL Libguides: How to Search for an Historical U.S. Patent.
  2. Congressional Research Service: The Patent Trial and Appeal Board and Inter Partes Review.
  3. Ropes & Gray: The Transformative Impact of AI on Patent Prior Art Searches.
  4. USPTO: Search for patents.
  5. Buchanan Ingersoll & Rooney PC: U.S. Patent Office Issues Additional Guidance on Use of AI Tools.

More… ↓

⤷  Subscribe

Details for Patent 9,662,450

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Emd Serono, Inc. PERGONAL menotropins For Injection 017646 August 22, 1975 ⤷  Subscribe 2029-05-13
Emd Serono, Inc. PERGONAL menotropins For Injection 017646 May 20, 1985 ⤷  Subscribe 2029-05-13
Eli Lilly And Company HUMATROPE somatropin For Injection 019640 June 23, 1987 ⤷  Subscribe 2029-05-13
Eli Lilly And Company HUMATROPE somatropin For Injection 019640 October 16, 1986 ⤷  Subscribe 2029-05-13
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.